Charles River Laboratories International, Inc. SEC filings CRL

Charles River Laboratories International, Inc. has 1,005 filings in SEC EDGAR's recent list, going back to Mar 1, 2016. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 27, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 26, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 27.

Charles River Laboratories International, Inc. SEC filings
Form Description Filed Period
DEF 14A Proxy statement Mar 31, 2026 May 5, 2026
DEF 14A Proxy statement Apr 2, 2025 May 20, 2025
DEFA14A Additional proxy material Apr 24, 2024 —
DEF 14A Proxy statement Mar 29, 2024 May 8, 2024
DEFA14A Additional proxy material May 1, 2023 —
DEF 14A Proxy statement Mar 30, 2023 —
DEFA14A Additional proxy material Apr 25, 2022 —
DEF 14A Proxy statement Mar 30, 2022 May 10, 2022
DEF 14A Proxy statement Mar 26, 2021 May 6, 2021
DEF 14A Proxy statement Mar 26, 2020 May 6, 2020
DEF 14A Proxy statement Apr 4, 2019 May 21, 2019
DEF 14A Proxy statement Mar 29, 2018 May 8, 2018
DEF 14A Proxy statement Mar 30, 2017 May 9, 2017
DEF 14A Proxy statement Mar 31, 2016 May 11, 2016

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
CRL (NYSE)
Fiscal year ends
December 27
Headquarters
Wilmington, MA
SEC filer status
Large accelerated filer
SEC CIK
1100682
Former names
CHARLES RIVER LABORATORIES INTERNATIONAL INC (until May 30, 2019); CHARLES RIVER LABORATORIES HOLDINGS INC (until Jan 28, 2000)

Other Services-Commercial Physical & Biological Research companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.